Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker.

Hsin Chih Albert Chao, Chia Ling Chung, Hsien An Pan, Pao-Chi Liao, Pao-Lin Kuo, Chao Chin Hsu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To understand the molecular basis of sperm-motility and to identify related novel motility biomarkers. Two-dimensional electrophoresis (2DE) followed by Reverse-phase-nano-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (RP-nano-HPLC-ESI-MS/MS) were applied to establish the human sperm proteome. Then the sperm proteome of moderate-motile human sperm fraction and that of good-motile human sperm fraction from pooled spermatozoa of forty normozoospermic donors (Group 1 subjects) were compared to identify the dysregulated proteins. Among these down-regulated proteins, Protein tyrosine phosphatase non-receptor type 14 (PTPN14) was chosen to reconfirm by Western blotting and semi-quantitative reverse transcription polymerase chain reaction. For clinical application, Western blotting and real-time reverse transcription polymerase chain reaction was performed to compare the expression level of PTPN14 in (Group 2 subjects) nine normozoospermic controls and thirty-three asthenozoospermic patients (including 21 mild asthenozoospermic cases and 12 severe cases). Finally, bioinformatic tools prediction and immunofluorescence assay were performed to elucidate the potential localization of PTPN14. The expression levels of three proteins were observed to be lower in the moderate-motile sperm fraction than in good-motile sperm of group 1 subjects. Among three proteins with persistent down-regulation in the moderate-motile sperm, we reconfirmed that the expression level of PTPN14 was significantly lower in both mRNA and protein levels from the moderate-motile sperm fraction. Further, down-regulation of PTPN14 was found at the translational and transcriptional level in the asthenozoospermic men. Finally, Bioinformatic tools prediction and immunofluorescence assay showed that PTPN14 maybe predominantly localized at the mitochondria in the midpiece of human ejaculated sperm. Proteomics tools were applied to identify three possible sperm motility-related proteins. Among these proteins, PTPN14 was highly likely a novel sperm-motility biomarker and a potential mitochondrial protein.

Original languageEnglish
Pages (from-to)851-861
Number of pages11
JournalJournal of assisted reproduction and genetics
Volume28
Issue number9
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Non-Receptor Protein Tyrosine Phosphatases
Sperm Motility
Spermatozoa
Biomarkers
Proteins
Proteome
Computational Biology
Reverse Transcription
Fluorescent Antibody Technique
Down-Regulation
Molecular Motor Proteins
Western Blotting
High Pressure Liquid Chromatography
Polymerase Chain Reaction
Electrospray Ionization Mass Spectrometry
Mitochondrial Proteins
Tandem Mass Spectrometry
Proteomics

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Genetics
  • Obstetrics and Gynaecology
  • Developmental Biology
  • Genetics(clinical)

Cite this

Chao, Hsin Chih Albert ; Chung, Chia Ling ; Pan, Hsien An ; Liao, Pao-Chi ; Kuo, Pao-Lin ; Hsu, Chao Chin. / Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker. In: Journal of assisted reproduction and genetics. 2011 ; Vol. 28, No. 9. pp. 851-861.
@article{ed5451d500a4437e8fc105c6b0ecf3e3,
title = "Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker.",
abstract = "To understand the molecular basis of sperm-motility and to identify related novel motility biomarkers. Two-dimensional electrophoresis (2DE) followed by Reverse-phase-nano-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (RP-nano-HPLC-ESI-MS/MS) were applied to establish the human sperm proteome. Then the sperm proteome of moderate-motile human sperm fraction and that of good-motile human sperm fraction from pooled spermatozoa of forty normozoospermic donors (Group 1 subjects) were compared to identify the dysregulated proteins. Among these down-regulated proteins, Protein tyrosine phosphatase non-receptor type 14 (PTPN14) was chosen to reconfirm by Western blotting and semi-quantitative reverse transcription polymerase chain reaction. For clinical application, Western blotting and real-time reverse transcription polymerase chain reaction was performed to compare the expression level of PTPN14 in (Group 2 subjects) nine normozoospermic controls and thirty-three asthenozoospermic patients (including 21 mild asthenozoospermic cases and 12 severe cases). Finally, bioinformatic tools prediction and immunofluorescence assay were performed to elucidate the potential localization of PTPN14. The expression levels of three proteins were observed to be lower in the moderate-motile sperm fraction than in good-motile sperm of group 1 subjects. Among three proteins with persistent down-regulation in the moderate-motile sperm, we reconfirmed that the expression level of PTPN14 was significantly lower in both mRNA and protein levels from the moderate-motile sperm fraction. Further, down-regulation of PTPN14 was found at the translational and transcriptional level in the asthenozoospermic men. Finally, Bioinformatic tools prediction and immunofluorescence assay showed that PTPN14 maybe predominantly localized at the mitochondria in the midpiece of human ejaculated sperm. Proteomics tools were applied to identify three possible sperm motility-related proteins. Among these proteins, PTPN14 was highly likely a novel sperm-motility biomarker and a potential mitochondrial protein.",
author = "Chao, {Hsin Chih Albert} and Chung, {Chia Ling} and Pan, {Hsien An} and Pao-Chi Liao and Pao-Lin Kuo and Hsu, {Chao Chin}",
year = "2011",
month = "1",
day = "1",
doi = "10.1007/s10815-011-9602-0",
language = "English",
volume = "28",
pages = "851--861",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "9",

}

Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker. / Chao, Hsin Chih Albert; Chung, Chia Ling; Pan, Hsien An; Liao, Pao-Chi; Kuo, Pao-Lin; Hsu, Chao Chin.

In: Journal of assisted reproduction and genetics, Vol. 28, No. 9, 01.01.2011, p. 851-861.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker.

AU - Chao, Hsin Chih Albert

AU - Chung, Chia Ling

AU - Pan, Hsien An

AU - Liao, Pao-Chi

AU - Kuo, Pao-Lin

AU - Hsu, Chao Chin

PY - 2011/1/1

Y1 - 2011/1/1

N2 - To understand the molecular basis of sperm-motility and to identify related novel motility biomarkers. Two-dimensional electrophoresis (2DE) followed by Reverse-phase-nano-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (RP-nano-HPLC-ESI-MS/MS) were applied to establish the human sperm proteome. Then the sperm proteome of moderate-motile human sperm fraction and that of good-motile human sperm fraction from pooled spermatozoa of forty normozoospermic donors (Group 1 subjects) were compared to identify the dysregulated proteins. Among these down-regulated proteins, Protein tyrosine phosphatase non-receptor type 14 (PTPN14) was chosen to reconfirm by Western blotting and semi-quantitative reverse transcription polymerase chain reaction. For clinical application, Western blotting and real-time reverse transcription polymerase chain reaction was performed to compare the expression level of PTPN14 in (Group 2 subjects) nine normozoospermic controls and thirty-three asthenozoospermic patients (including 21 mild asthenozoospermic cases and 12 severe cases). Finally, bioinformatic tools prediction and immunofluorescence assay were performed to elucidate the potential localization of PTPN14. The expression levels of three proteins were observed to be lower in the moderate-motile sperm fraction than in good-motile sperm of group 1 subjects. Among three proteins with persistent down-regulation in the moderate-motile sperm, we reconfirmed that the expression level of PTPN14 was significantly lower in both mRNA and protein levels from the moderate-motile sperm fraction. Further, down-regulation of PTPN14 was found at the translational and transcriptional level in the asthenozoospermic men. Finally, Bioinformatic tools prediction and immunofluorescence assay showed that PTPN14 maybe predominantly localized at the mitochondria in the midpiece of human ejaculated sperm. Proteomics tools were applied to identify three possible sperm motility-related proteins. Among these proteins, PTPN14 was highly likely a novel sperm-motility biomarker and a potential mitochondrial protein.

AB - To understand the molecular basis of sperm-motility and to identify related novel motility biomarkers. Two-dimensional electrophoresis (2DE) followed by Reverse-phase-nano-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (RP-nano-HPLC-ESI-MS/MS) were applied to establish the human sperm proteome. Then the sperm proteome of moderate-motile human sperm fraction and that of good-motile human sperm fraction from pooled spermatozoa of forty normozoospermic donors (Group 1 subjects) were compared to identify the dysregulated proteins. Among these down-regulated proteins, Protein tyrosine phosphatase non-receptor type 14 (PTPN14) was chosen to reconfirm by Western blotting and semi-quantitative reverse transcription polymerase chain reaction. For clinical application, Western blotting and real-time reverse transcription polymerase chain reaction was performed to compare the expression level of PTPN14 in (Group 2 subjects) nine normozoospermic controls and thirty-three asthenozoospermic patients (including 21 mild asthenozoospermic cases and 12 severe cases). Finally, bioinformatic tools prediction and immunofluorescence assay were performed to elucidate the potential localization of PTPN14. The expression levels of three proteins were observed to be lower in the moderate-motile sperm fraction than in good-motile sperm of group 1 subjects. Among three proteins with persistent down-regulation in the moderate-motile sperm, we reconfirmed that the expression level of PTPN14 was significantly lower in both mRNA and protein levels from the moderate-motile sperm fraction. Further, down-regulation of PTPN14 was found at the translational and transcriptional level in the asthenozoospermic men. Finally, Bioinformatic tools prediction and immunofluorescence assay showed that PTPN14 maybe predominantly localized at the mitochondria in the midpiece of human ejaculated sperm. Proteomics tools were applied to identify three possible sperm motility-related proteins. Among these proteins, PTPN14 was highly likely a novel sperm-motility biomarker and a potential mitochondrial protein.

UR - http://www.scopus.com/inward/record.url?scp=85027920527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027920527&partnerID=8YFLogxK

U2 - 10.1007/s10815-011-9602-0

DO - 10.1007/s10815-011-9602-0

M3 - Article

VL - 28

SP - 851

EP - 861

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 9

ER -